Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[1/1 nodo-ventricular conduction atrial flutter with amiodarone].

L Perdrix-Andujar1, O Paziaud, G Ricard

  • 1Services de Cardiologie, HEGP, rue Leblanc, Paris

Archives Des Maladies Du Coeur Et Des Vaisseaux
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remote patient monitoring for chronic heart failure in France: When an innovative funding program (ETAPES) meets an innovative solution (Satelia® Cardio).

Digital health·2022
Same author

[Editorial].

Presse medicale (Paris, France : 1983)·2016
Same author

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Somatic mosaicism for a FOXG1 mutation: diagnostic implication.

Clinical genetics·2014
Same author

Antithrombotic treatment of atrial fibrillation: new insights.

Thrombosis research·2012
Same author

MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies.

Clinical genetics·2012

This study reports a rare case of 1/1 atrial flutter with amiodarone, highlighting its pro-arrhythmic effects and diagnostic challenges. Early diagnosis via esophageal recording is crucial for managing this poorly tolerated rhythm disturbance.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • 1/1 atrial flutter is a known complication of Class I anti-arrhythmics.
  • It is rarely associated with Class III anti-arrhythmics due to AV node refractoriness preventing 1/1 conduction.
  • Only seven cases of 1/1 atrial flutter with amiodarone have been previously reported.

Observation:

  • A new case of 1/1 atrial flutter occurred in a patient treated with amiodarone.
  • This case demonstrated amiodarone's pro-arrhythmic effects, including flutter cycle prolongation and infra-Hissian block.
  • The case also illustrated mechanisms of 1/1 conduction, such as prolonged flutter cycles and significant AV node permeability.

Findings:

  • The case highlights the pro-arrhythmic potential of amiodarone, leading to 1/1 atrial flutter.

Related Experiment Videos

  • Diagnostic difficulties were encountered, emphasizing the need for advanced techniques like esophageal recording.
  • The rhythm disturbance was poorly tolerated, underscoring the importance of prompt diagnosis.

    • Implications:

    • This case expands the understanding of amiodarone's complex electrophysiological effects.
    • It stresses the importance of recognizing and diagnosing 1/1 atrial flutter, even with Class III agents.
    • Preventive strategies may involve amiodarone, digitalis, beta-blockers, or bradycardic calcium channel blockers.